(Iodomethyl)cyclopentane → (3S,5S)-3-(Cyclopentylmethyl)-3-methyl-5-phenylmorpholin-2-one
反応式
[CH3:1][C:2]1[C:3](=[O:14])[O:4][CH2:5][C@H:6]([C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=2)[N:7]=1.I[CH2:16][CH:17]1[CH2:21][CH2:20][CH2:19][CH2:18]1>>[CH:17]1([CH2:16][C@@:2]2([CH3:1])[C:3](=[O:14])[O:4][CH2:5][C@H:6]([C:8]3[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=3)[NH:7]2)[CH2:21][CH2:20][CH2:19][CH2:18]1参加物
3
実験手順
The compound was prepared according to the procedure outlined in Preparation 1 using (5S)-3-methyl-5-phenyl-5,6-dihydro-2H-1,4-oxazin-2-one (1 g, 5.28 mmol, see WO-A-02/051983) and (iodomethyl)cyclopentane. The total amount of compound synthesised was 0.426 g.
後処理
- customThe compound was prepared
- customThe total amount of compound synthesised
出典と根拠
- ORDレコード
- ord-558f2c2f0f98440c8da23e4e2696968f
- 出典データセット
- uspto-grants-2009_11
- 特許番号
- US07612226B2
反応ノート
読み込み中…